introduct
communityacquir
pneumonia
cap
requir
prompt
treatment
diagnosi
complex
improv
bacteri
cap
diagnosi
biomark
evalu
use
chest
xray
infiltr
cap
gold
standard
produc
conflict
result
analyz
diagnost
accuraci
biomark
suspect
cap
adult
visit
emerg
depart
cap
diagnosi
establish
adjud
committe
found
judgment
systemat
multidetector
thorac
ct
scan
method
ancillari
studi
multicent
prospect
studi
evalu
impact
systemat
thorac
ct
scan
cap
diagnosi
sensit
specif
creactiv
protein
crp
procalcitonin
pct
evalu
systemat
nasopharyng
multiplex
respiratori
viru
pcr
perform
inclus
adjud
committe
classifi
cap
diagnost
probabl
likert
scale
base
avail
data
result
two
hundr
patient
suspect
cap
analyz
adjud
committe
classifi
patient
definit
cap
probabl
possibl
exclud
includ
patient
pulmonari
infiltr
chest
xray
among
patient
radiolog
pulmonari
infiltr
final
classifi
exclud
virus
identifi
pcr
patient
classifi
definit
area
curv
confid
interv
ci
crp
ci
pct
detect
definit
cap
crp
threshold
mgl
result
posit
predict
valu
neg
predict
valu
pct
cutoff
result
satisfactori
posit
neg
predict
valu
crp
pct
accuraci
improv
exclus
definit
viral
cap
case
conclus
patient
suspect
cap
visit
emerg
depart
diagnost
accuraci
crp
pct
insuffici
confirm
cap
diagnosi
establish
use
gold
standard
includ
thorac
ct
scan
diagnost
accuraci
biomark
also
insuffici
distinguish
bacteri
cap
viral
cap
trial
registr
clinicaltrialsgov
registri
februari
communityacquir
pneumonia
cap
frequent
seen
diseas
high
morbid
mortal
account
hospit
year
repres
seventh
lead
caus
death
usa
cap
prognosi
depend
rapid
specif
treatment
ideal
initi
within
four
hour
later
eight
hour
diagnosi
cap
diagnosi
base
cluster
nonspecif
pulmonari
gener
symptom
increas
biomark
reflect
system
inflammatori
respons
syndrom
sir
presenc
new
parenchym
infiltr
chest
xray
howev
cap
diagnosi
remain
uncertain
mani
case
altern
diagnos
cardiac
failur
acut
bronchiti
chronic
obstruct
pulmonari
diseas
copd
exacerb
pulmonari
embol
neoplasia
sepsi
part
uncertainti
cap
diagnosi
may
due
high
rate
chest
xray
misdiagnosi
diagnosi
cap
frequent
infiltr
noninfecti
origin
coexist
pulmonari
gener
symptom
diagnosi
cap
often
ignor
lung
infiltr
limit
visibl
hidden
due
superposit
recent
publish
studi
thorac
ct
scan
systemat
perform
popul
clinic
suspect
cap
patient
visit
emerg
depart
cap
escap
studi
show
cap
diagnosi
base
chest
xray
led
fals
cap
diagnosi
mani
patient
among
cap
suspect
patient
radiolog
pulmonari
infiltr
cap
diagnosi
exclud
around
patient
base
ct
scan
result
contrari
among
patient
without
radiolog
pulmonari
infiltr
onethird
pulmonari
infiltr
thorac
ctscan
also
report
isol
virus
onethird
patient
sever
attempt
made
improv
cap
diagnosi
base
biomark
creactiv
protein
crp
procalcitonin
pct
howev
conflict
data
reliabl
could
due
consider
cap
diagnosi
base
chest
xray
establish
pulmonari
infect
present
studi
aim
analyz
crp
pct
valu
popul
escap
studi
report
cap
diagnosi
establish
adjud
committe
found
judgment
usual
avail
data
systemat
multidetector
thorac
ct
scan
perform
inclus
result
followup
also
analyz
whether
viral
etiolog
definit
cap
base
polymeras
chain
reaction
pcr
multiplex
nasopharyng
swab
interf
accuraci
biomark
set
escap
multicent
prospect
intervent
studi
entitl
earli
thorac
ctscan
communityacquir
pneumonia
emerg
depart
escap
conduct
novemb
januari
four
emerg
depart
ed
four
tertiari
teach
hospit
pari
franc
design
measur
impact
thorac
ct
scan
clinic
decis
studi
sponsor
monitor
pari
public
health
hospit
fund
french
ministri
health
french
health
author
agenc
national
de
de
medica
et
produit
de
ansm
institut
review
board
protect
human
subject
approv
studi
protocol
patient
inform
consent
procedur
enrol
patient
provid
written
inform
consent
inclus
protocol
regist
clinicaltrialgov
websit
pacscan
acronym
french
translat
english
escap
acronym
ethic
committe
ile
de
franc
de
protect
de
personn
pari
approv
studi
protocol
primari
object
compar
crp
pct
valu
four
differ
categori
cap
level
certainti
use
adjud
committe
classif
four
categori
absenc
cap
hereaft
refer
exclud
cap
diagnosi
possibl
cap
probabl
cap
definit
cap
secondari
object
assess
whether
crp
pct
associ
cap
diagnosi
use
sensit
analys
three
success
subgroup
chosen
priori
specif
consid
patient
classifi
exclud
cap
diagnosi
definit
cap
ie
patient
level
certainti
highest
patient
exclud
cap
diagnosi
diagnos
extrapulmonari
infecti
diseas
may
increas
biomark
valu
taken
account
exclud
cap
group
patient
classifi
viral
cap
taken
account
definit
cap
group
pct
report
lower
viral
infect
compar
bacteri
infect
consecut
adult
multidetector
thorac
ctscan
perform
chest
xray
ideal
within
four
hour
follow
inclus
chest
xray
thorac
ctscan
perform
use
standard
protocol
four
level
cap
probabl
accord
ct
scan
defin
definit
systemat
alveolar
condens
alveolar
condens
peripher
local
ground
glass
opac
bronchiolar
focal
multifoc
micronodul
probabl
peripher
alveolar
condens
retractil
systemat
alveolar
condens
diffus
ground
glass
opac
possibl
pulmonari
infarct
exclud
pulmonari
mass
abnorm
normal
imag
scan
view
record
dvd
base
data
collect
baselin
standard
case
report
form
dvd
record
pictur
xray
ctscan
blind
local
interpret
adjud
committe
consist
three
independ
senior
expert
infecti
diseas
pneumolog
radiolog
retrospect
assign
probabl
cap
diagnosi
use
likert
scale
avail
data
includ
patient
discharg
summari
followup
data
obtain
assist
investig
contact
phone
either
patient
rel
gener
practition
day
studi
gold
standard
cap
diagnosi
assess
adjud
committe
altern
diagnos
establish
exclud
cap
classifi
noncap
pulmonari
diseas
extrapulmonari
infecti
diseas
other
blood
sampl
collect
inclus
sodium
heparintr
tube
centrifug
store
complet
studi
crp
pct
concentr
measur
posteriori
plasma
collect
see
addit
file
methodolog
except
patient
marker
dosag
perform
emerg
practition
initi
nasopharyng
swab
collect
enrol
place
middl
virocult
mwe
transport
medium
sampl
kept
room
temperatur
sent
virolog
laboratori
bichat
claud
bernard
hospit
pari
soon
possibl
collect
sampl
frozen
thaw
multiplex
pcr
assay
maastricht
netherland
perform
nasopharyng
swab
detect
respiratori
virus
coronaviru
human
metapneumoviru
hmpv
influenza
b
virus
parainfluenza
virus
respiratori
syncyti
viru
rsv
b
rhinoviru
adenoviru
intracellular
bacteria
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
one
reaction
multiplex
pcr
result
avail
adjud
committe
routin
microbiolog
examin
also
perform
discret
emerg
physician
includ
blood
cultur
sputum
cultur
antigenuria
see
addit
file
methodolog
cap
classifi
definit
consid
viral
origin
multiplex
pcr
posit
least
one
respiratori
virus
bacteria
found
use
pcr
routin
bacteri
microbiolog
sampl
sputum
blood
cultur
antigenuria
perform
baselin
followup
characterist
describ
mean
standard
deviat
sd
median
interquartil
rang
iqr
continu
variabl
normal
distribut
skew
distribut
respect
percentag
categor
variabl
total
studi
popul
studi
group
perform
chisquar
fisher
exact
test
appropri
qualit
variabl
student
mannwhitney
test
continu
variabl
skew
distribut
compar
baselin
patient
characterist
studi
outcom
studi
group
distribut
valu
biomark
determin
differ
popul
patient
use
boxplot
perform
crp
pct
predict
definit
cap
evalu
sensit
analysi
definit
cap
vs
exclud
cap
crp
evalu
sever
cutoff
point
mgl
mgl
mgl
mgl
mgl
valu
use
previou
studi
sever
cutoff
point
pct
chosen
level
two
level
suspect
bacteri
infect
state
manufactur
ie
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
likelihood
ratio
calcul
receiv
oper
characterist
roc
curv
drawn
area
curv
auc
comput
optim
cutoff
identifi
maxim
youden
index
compar
biomark
valu
patient
exclud
cap
definit
cap
optim
cutoff
crp
pct
sensit
analys
perform
combin
crp
pct
cutoff
multivari
logist
regress
model
built
identifi
factor
associ
definit
cap
compar
exclud
cap
diagnosi
exclud
exclud
cap
diagnosi
group
patient
extrapulmonari
infecti
diseas
variabl
p
valu
bivari
analysi
enter
multivari
logist
regress
backward
stepwis
approach
discrimin
evalu
cindex
confid
interv
ci
calibr
evalu
hosmer
lemeshow
goodnessoffit
test
test
twosid
pvalu
consid
denot
statist
signific
statist
analys
perform
use
spss
statist
softwar
version
spss
inc
chicago
il
usa
two
hundr
patient
suspect
cap
escap
studi
includ
present
studi
crp
pct
assay
nasopharyng
swab
multiplex
pcr
avail
fig
characterist
patient
age
age
gender
probabl
cap
diagnosi
adjud
committe
significantli
differ
patient
escap
studi
summar
tabl
crp
pct
assay
perform
base
emerg
practition
initi
patient
crp
pct
perform
posteriori
plasma
sampl
remain
patient
sex
ratio
approxim
half
patient
year
age
older
pulmonari
infiltr
seen
chest
xray
patient
thorac
ctscan
exclud
cap
diagnosi
patient
contrari
thorac
ctscan
reveal
parenchym
infiltr
patient
without
infiltr
chest
xray
base
avail
data
includ
multidetector
ct
scan
result
exclud
pcr
result
adjud
crp
pct
distribut
patient
present
fig
statist
signific
differ
two
group
exclud
cap
vs
definit
cap
demonstr
sever
cutoff
point
crp
pct
tabl
crp
valu
mgl
result
ppv
npv
pct
valu
result
satisfactori
ppv
npv
two
biochem
marker
abil
predict
cap
evalu
roc
curv
auc
ci
optim
cutoff
mgl
crp
fig
ci
optim
cutoff
l
pct
fig
sensit
analys
combin
crp
pct
use
optim
cutoff
result
ppv
npv
use
pct
cutoff
result
better
ppv
npv
tabl
present
studi
novel
patient
prospect
benefit
extens
investig
determin
diagnosi
cap
ed
includ
earli
multidetector
thorac
ctscan
adjud
committe
led
correct
cap
diagnosi
previous
base
chest
xray
high
number
patient
extens
character
patient
crp
pct
lack
oper
precis
allow
decisionmak
process
rule
confirm
diagnosi
cap
even
select
subgroup
clinic
characterist
patient
includ
substudi
consist
current
literatur
previous
report
patient
frequent
histori
respiratori
disord
cancer
congest
heart
failur
design
escap
studi
requir
exclus
patient
within
highest
crb
categori
limit
inclus
patient
older
may
explain
mean
age
patient
year
fall
within
lower
valu
report
elsewher
data
identifi
microbi
agent
respons
diseas
collect
usual
techniqu
multiplex
pcr
viral
identif
use
nasopharyng
pcr
reveal
viral
respiratori
infect
approxim
onethird
case
concord
valu
report
literatur
therefor
believ
result
extrapol
emerg
patient
suffer
cap
present
studi
patient
recruit
basi
initi
clinic
assess
diagnosi
cap
therefor
believ
characterist
patient
close
correspond
lead
practition
consid
possibl
diagnosi
cap
patient
design
studi
allow
us
confirm
refut
cap
diagnosi
high
level
certainti
result
confirm
poor
predict
valu
clinic
symptom
new
onset
system
featur
symptom
acut
lower
respiratori
tract
ill
identifi
cap
patient
inde
clinic
present
exclud
cap
patient
similar
definit
cap
patient
except
fever
cough
frequent
definit
cap
patient
furthermor
design
also
reveal
combin
clinic
symptom
chest
xray
result
led
cap
misdiagnosi
high
number
patient
includ
whose
cap
diagnosi
exclud
adjud
committe
would
consid
possibl
probabl
definit
cap
without
use
ct
scan
low
specif
clinicalstandard
radiolog
evalu
led
consider
either
noninfecti
pulmonari
diseas
cardiac
failur
pulmonari
embol
pulmonari
neoplasia
bronchiti
extrapulmonari
infecti
diseas
cap
note
diseas
also
associ
increas
biomark
valu
rais
concern
previou
evalu
biomark
capsuspect
patient
use
clinic
standard
radiolog
chest
xray
evalu
gold
standard
cap
diagnosi
use
biomark
advoc
improv
diagnosi
manag
patient
lower
respiratori
tract
infect
howev
issu
still
unresolv
conflict
posit
studi
median
valu
biomark
increas
level
certainti
cap
diagnosi
unabl
establish
discrimin
valu
pct
recent
data
suggest
crp
could
help
assist
diagnosi
lower
respiratori
tract
infect
lrti
studi
although
crp
seem
discrimin
pct
neither
experiment
exclus
extrapulmonari
bacteri
infect
exclud
cap
group
exclus
viral
cap
definit
cap
patient
group
made
possibl
determin
discrimin
cutoff
combin
crp
pct
discrimin
biomark
separ
oper
algorithm
releas
assist
physician
prescrib
antimicrobi
therapi
accord
strategi
pct
concentr
higher
prompt
administr
antibiot
patient
suspect
lrti
studi
valu
associ
poor
perform
addit
mean
pct
level
remain
threshold
exclud
cap
patient
without
infecti
disord
definit
cap
presum
relat
viru
therefor
gold
standard
diagnosi
cap
may
influenc
perform
util
pct
set
studi
limit
first
adjud
committe
blind
valu
biomark
measur
bedsid
patient
crp
pct
cap
classif
could
thu
influenc
result
howev
lack
statist
signific
differ
mean
crp
pct
valu
definit
cap
case
whether
biomark
avail
adjud
committe
argu
major
impact
result
adjud
committe
classif
second
anoth
critic
point
prescript
antibiot
therapi
previou
inclus
exclud
previouslytr
cap
patient
may
alter
biomark
perform
reduc
yield
bacteri
cultur
although
popul
reflect
usual
emerg
depart
practic
third
multiplex
pcr
perform
nasopharyng
sampl
lower
respiratori
tract
sampl
allow
definit
confirm
viral
origin
cap
howev
recent
larg
studi
cap
patient
report
viral
etiolog
cap
compar
rate
find
upper
respiratori
tract
shed
control
popul
without
cap
explor
year
season
final
even
multidetector
thorac
ct
scan
better
imag
examin
xray
explor
chest
invas
local
microbiolog
sampl
would
provid
diagnosi
certainti
given
divers
clinic
radiolog
cap
present
cap
diagnosi
often
uncertain
popul
patient
treat
emerg
room
clinic
symptom
evok
cap
neither
crp
pct
cutoff
valu
carri
suffici
weight
confirm
refut
cap
diagnosi
bedsid
underlin
biomark
telltal
host
inflammatori
respons
intrus
microorgan
independ
site
infect
result
base
systemat
thorac
ct
scan
evalu
capsuspect
patient
argu
use
crp
pct
routin
care
diagnos
cap
certainti
patient
visit
ed
suspect
cap
